Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 68382-548

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 68382-548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine HCl Er Capsules (Ad59ebbd 2896 48a1 A53c 719c04593a9a 01)

FDA Label Image

Memantine HCl Er Capsules (Ad59ebbd 2896 48a1 A53c 719c04593a9a 02)

FDA Label Image

Memantine HCl Er Capsules (Ad59ebbd 2896 48a1 A53c 719c04593a9a 03)

FDA Label Image

Memantine HCl Er Capsules (Ad59ebbd 2896 48a1 A53c 719c04593a9a 04)

FDA Label Image

Memantine HCl Er Capsules (Ad59ebbd 2896 48a1 A53c 719c04593a9a 05)

FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 7 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 06)

Memantine Hydrochloride Extended-release Capsules, 7 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 06)
This is a description of a medication called Memantine Hydrochloride Extended-release. The medication is contained in capsules, each containing 7mg of USP memantine. The recommended dosage is stated to be found in the package insert or from a healthcare professional. There are storage instructions to keep the capsules at controlled room temperature and to keep them out of the reach of children. The manufacturer is Cadila Healthcare Ltd located in Ahmedabad, India and the distributor is Zydus Pharmaceuticals USA Inc. with a location in Pennington.*
FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 14 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 07)

FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 21 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 08)

Memantine Hydrochloride Extended-release Capsules, 21 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 08)
This is a description of Memantine Hydrochloride Extended-release capsules containing 21 mg of the active ingredient in each capsule. There are 70 capsules in the pack and the usual dosage information is printed on the package insert. It is recommended to store the capsules at a controlled room temperature and keep them out of reach of children. The product is manufactured by Cadila Healthcare Ltd. in Ahmedabad, India and distributed in the USA by Zydus Pharmaceuticals.*
FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 28 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 09)

Memantine Hydrochloride Extended-release Capsules, 28 mg (Ad59ebbd 2896 48a1 A53c 719c04593a9a 09)
This is a description of a medication called Memantine Hydrochloride in extended-release form. The manufacturer is Casils Healthcare Ltd. from India, and it is distributed by Zydus Pharmaceuticals in the USA. No further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.